Search hospitals > Iowa > Sioux City
Velocity Clinical Research
Claim this profileSioux City, Iowa 51106
Conducts research for Obesity
Conducts research for Type 2 Diabetes
Conducts research for Coronavirus
Conducts research for Obesity/Overweight
Conducts research for Weight Loss
5 reported clinical trials
1 medical researcher
Summary
Velocity Clinical Research is a medical facility located in Sioux City, Iowa. This center is recognized for care of Obesity, Type 2 Diabetes, Coronavirus, Obesity/Overweight, Weight Loss and other specialties. Velocity Clinical Research is involved with conducting 5 clinical trials across 14 conditions. There are 1 research doctors associated with this hospital, such as David Ensz, MD.Top PIs
Clinical Trials running at Velocity Clinical Research
Obesity
Type 2 Diabetes
Obesity/Overweight
Weight Loss
Diabetes
Naltrexone + Bupropion
for Obesity
This trial studies the effects of a medication combination (naltrexone and bupropion) on heart health. It targets patients to see if this treatment increases the risk of major heart problems. The study also includes advice on diet and exercise. Naltrexone and bupropion have been used in combination for weight loss, but they have been associated with various adverse effects, including neuropsychiatric disorders and cardiovascular risks.
Recruiting2 awards Phase 423 criteria
BI 456906
for Obesity
This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 30 kg/m² or more, or a BMI of 27 kg/m² or more and at least one health problem related to their weight. People with type 2 diabetes cannot take part in this study. Only people who have previously not managed to lose weight by changing their diet can participate. The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity to lose weight. Participants are divided into 3 groups by chance, like drawing names from a hat. 2 groups get different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants inject survodutide or placebo under their skin once a week for about one and a half years. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 7 months. During this time, it is planned that participants visit the study site up to 14 times and receive 6 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. The results are compared between the groups to see whether the treatment works.
Recruiting1 award Phase 37 criteria
BI 456906
for Diabetes and Obesity
This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exercise or with specific diabetes medications. Only people who have previously not managed to lose weight by changing their diet can participate. The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity who also have diabetes to lose weight. Participants are divided into 3 groups by chance, like drawing names from a hat. 2 groups get different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants inject survodutide or placebo under their skin once a week for about one and a half years. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 7 months. During this time, it is planned that participants visit the study site up to 14 times and receive 6 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The study staff also regularly measure participants' body weight. The results are compared between the groups to see whether the treatment works.
Recruiting1 award Phase 37 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Velocity Clinical Research?
Velocity Clinical Research is a medical facility located in Sioux City, Iowa. This center is recognized for care of Obesity, Type 2 Diabetes, Coronavirus, Obesity/Overweight, Weight Loss and other specialties. Velocity Clinical Research is involved with conducting 5 clinical trials across 14 conditions. There are 1 research doctors associated with this hospital, such as David Ensz, MD.